Startups

Cell-therapy operating company within Gilead Sciences. Corporate investment participation does not identify a standalone venture capital firm.

Investments

$115M2025-11-20	Aspen Neuroscience	ARCH Venture Partners, S32, Axon Partners Group, OrbiMed, Cormorant Asset Management, Lifeforce Capital, Kite, a Gilead Company
$115M2025-11-20	Aspen Neuroscience	ARCH Venture Partners, S32, Axon Partners Group, Cormorant Asset Management, Lifeforce Capital, Avon Ventures, Kite, a Gilead Company, Section 32
$35M2020-02-05	Vineti	S32, Casdin Capital, Threshold Ventures, Lifeforce Capital, Kite, a Gilead Company, Hive Ventures, Section 32

SHOW MORE